Anova Health Institute

admin_Anova

Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data

Abstract Same-day initiation (SDI) of antiretroviral therapy (ART) has been recommended to improve ART programme outcomes in South Africa since August 2017. This study assessed implementation of SDI over time in two South African districts, describing the characteristics of same-day initiators and evaluating the impact of SDI on retention in ART care. Routine data were analysed for HIV-infected adults who were newly initiating ART in Johannesburg or Mopani Districts between October 2017 and June 2018. Characteristics of same-day ART initiators were compared to later initiators, and losses to follow-up (LTFU) to six months were assessed using Kaplan Meier survival analysis and multivariate logistic regression. The dataset comprised 32 290 records (29 964 from Johannesburg and 2 326 from Mopani). The overall rate of SDI was 40.4% (n = 13 038), increasing from 30.3% in October 2017 to 54.2% in June 2018. Same-day ART initiators were younger, more likely to be female and presented with less advanced clinical disease than those initiating treatment at later times following diagnosis (p<0.001 for all). SDI was associated with disengagement from care: LTFU was 30.1% in the SDI group compared to 22.4%, 19.8% and 21.9% among clients initiating ART 1–7 days, 8–21 days and ≥22 days after HIV diagnosis, respectively (p<0.001). LTFU was significantly more likely among clients in Johannesburg versus Mopani (adjusted odds ratio (aOR) = 1.43, p<0.001) and among same-day versus later initiators (aOR = 1.45, p<0.001), while increasing age reduced LTFU (aOR = 0.97, p<0.001). In conclusion, SDI has increased over time as per national guidelines, but there is serious concern regarding the reduced rate of retention among same-day initiators. Nevertheless, SDI may result in a net programmatic benefit provided that interventions are implemented to support client readiness for treatment and ongoing engagement in ART care, particularly among younger adults in large ART programmes such as Johannesburg. Introduction South Africa’s antiretroviral therapy (ART) programme for the treatment of human immunodeficiency virus (HIV) infection was launched in 2004. At the time, 4.1 million adults over the age of 15 years were living with HIV and within a decade, an additional 2.2 million adults were infected with the virus [1]. National ART guidelines evolved over this time to treat increasing numbers of HIV-infected clients and to provide improved care and treatment services. South Africa’s ART programme has since grown to be the largest world-wide, with an estimated 4.2 million adults receiving ART in 2017 [2]. When South Africa’s ART programme first started, adults with CD4 counts <200 cells/mm3 were eligible to initiate treatment [3]. The CD4 cut-off was raised to 350 cells/mm3 in August 2011 [4] and to 500 cells/mm3 from January 2015 [5]. However, despite the expanding ART eligibility criteria, South Africa faced challenges in reaching the second 90-90-90 target, namely the provision of ART to 90% of HIV diagnosed individuals, with only 56.9% of HIV-diagnosed adults receiving ART nationally by the middle of 2015 [6]. In September 2016 the National Department of Health (NDoH) implemented universal test and treat (UTT) whereby all adults became eligible to initiate ART irrespective of CD4 count [7], but adult ART coverage increased only minimally to 61% in 2017 [2]. This is consistent with findings from a South African study regarding the significantly decreased likelihood of ART initiation with increasing baseline CD4 count [8], as clients feel “too healthy” to initiate treatment [9]. In addition, numerous other barriers to ART initiation may have impacted treatment coverage rates, including distance to testing centres, transport costs, over-busy clinics and the need for repeat facility visits at the time ART eligibility was being assessed [10, 11]. In order to address ongoing challenges with ART initiation, the NDoH implemented same-day initiation (SDI), namely ART initiation on the same day as HIV diagnosis [12]. The NDoH circular signed in August 2017 requested all public health facilities to scale up ART initiation for all HIV-infected individuals as per UTT guidelines, with an emphasis on providing SDI for individuals newly diagnosed with HIV who were clinically and psychologically ready for lifelong ART [12]. Clinical readiness encompasses screening for symptoms of tuberculosis (TB) and cryptococcal meningitis, as initiation of ART must be delayed in clients with these conditions in order to avoid complications such as immune reconstitution inflammatory syndrome [13]. When appropriately implemented, SDI has the potential to prevent the loss of ART-eligible clients from pre-ART care prior to treatment initiation, a challenge that has been described in multiple sub-Saharan African settings, including South Africa [14, 15]. A number of randomised trials of rapid ART initiation have indeed demonstrated multiple benefits of rapid initiation compared to later ART start, including improved ART uptake by 3 months, increased retention in care at 12 months, higher rates of 12-month viral suppression and reduced risk of mortality [16–19]. However, randomised trials precisely control the environment in which the intervention is being assessed, and it therefore cannot be automatically assumed that findings from these trials regarding the benefits of SDI would translate into routine settings [20]. Although a number of observational studies of SDI in sub-Saharan African settings have also been performed, these studies focussed on pregnant and breastfeeding women and the results may therefore not be generalizable to the wider adult population [21–24]. Other routine studies have been limited to hospitals [25] or have described SDI in the context of specialised interventions such as peer-delivered linkage case management or a revised ART initiation counselling model implemented at a single facility [26, 27]. There is thus a paucity of data regarding the implementation of a national policy for SDI across the whole adult population in routine sub-Saharan African settings. In order to fill this gap, this study aimed to analyse routine programme data to assess implementation of SDI over time and its impact on programme outcomes in an urban and rural district of South Africa. Specifically, this study aimed to compare characteristics of clients who initiate ART on the same day as HIV diagnosis to clients who initiate treatment at later time points after diagnosis, and to assess

Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data Read More »

Invitation To Bid: Supply of 11 Motor Vehicles

Anova Health Institute requires the services of suitable and experienced motor vehicle suppliers for the supply of the following motor vehicles: Motor Vehicle Brand Type of Vehicle (model) No. of Vehicles Iveco/Mercedes Benz/VW (or similar) Panel Van (for subsequent conversion to Mobile Clinic) 11 Closing Date Date: 21 October 2019 Time: 15h00 The time stipulated is in accordance with Telkom time, available by dialing 1026. Further submission details are contained in the bid document. No faxed or emailed bids will be accepted. NO late submissions will be considered. Request for bid document and submission of bids information Submission Address: Reception Nexia SAB&T, 119 Witch-Hazel Ave, Highveld Technopark, Centurion Bid documentation will be available electronically in PDF format, on request by email, from Johann Kilian at johann.kilian@nexia-sabt.co.za or in exceptional circumstances, printed format of the bid documentation will be available during office hours, for collection only from Johann Kilian at 012 682 8800 on prior arrangement. Office hours are between 08h00 and 16h30, Mondays to Fridays, excluding public holidays. Procurement process administered by Nexia SAB&T

Invitation To Bid: Supply of 11 Motor Vehicles Read More »

Liesl Lintvelt

Liesl Lintvelt (LLB) is an admitted attorney in the High Court of South Africa that has extensive experience in litigating on personal injury and medical negligence claims. Seeing first hand the devastating effect that HIV/Aids has on the every day lives of people, she is very excited to be part of an organization that truly makes a difference in the fight against the epidemic.

Liesl Lintvelt Read More »

René Kenosi

René Kenosi is a qualified chartered accountant who provides internal audit, risk management, corporate training, and management consulting services. She is a former Chair of the Independent Board for Auditors, and has served on many Boards and Audit committees and the Advisory Council for the Minister of Home Affairs.

René Kenosi Read More »

Moyahabo Mabitsi

Having worked at Far East Rand Hospital, Voortrekker Hospital and the NHLS Cytology unit as a Medical Officer, Dr Moyahabo Mabitsi has worked in Public Health Programmes in different positions within Anova for the past eight years. She has a sound knowledge of the public health system in South Africa, particularly the primary health care system. She has been involved in implementation of TB/HIV/PMTCT policies/guidelines at Primary Health Care level; this included the rollout of the NIMART programme in Johannesburg District in 2010. In her roles as TB Technical Advisor and manager of Anova’s Johannesburg District PEPFAR programme, she has provided capacity building for DoH clinicians, and facilitated the provision of TA to sub-district and District level DoH management on implementations and review of TB/HIV and related programmes. In her current role, Dr Mabitsi provides oversight on implementation of the APACE program activities across Anova supported districts; Mopani, Capricorn, Sedibeng and Johannesburg districts. In this role, she provides leadership to, and is supported by Anova District Program Managers in the four Districts.

Moyahabo Mabitsi Read More »

Susan Kekana

Susan Kekana (Degree in Nursing) is Anova’s Executive Government Liaison. She held Senior Management positions at both the Gauteng Department of Health and the City of Johannesburg. She is one of Anova’s most senior and respected managers and has mentored many of our younger managers. Susan brings to the Board a wealth of experience in the public health sector.

Susan Kekana Read More »

Helen Struthers

Helen Struthers (MSc, MBA, PhD) is the CEO of Anova and an Honorary Research Associate in the Division of Infectious Diseases & HIV Medicine, Department of Medicine at UCT. Previously she worked in the mining sector, but has worked and conducted research in the health sector since 2001 focusing on mitigating the impact of the HIV epidemic.

Helen Struthers Read More »

From Top to Bottom – A Sex-Positive Approach For Men Who Have Sex With Men

This manual draws on the experience of the Anova Health Institute’s Health4Men project that provides sexual health services for men who have sex with men (MSM) in South Africa. The manual is a resource to assist healthcare workers to provide appropriate and accessible psychosocial and medical care for MSM. The Health4Men project was initiated in 2008 when the South African Department of Health started to focus on providing HIV- related services for MSM in accordance with the National Strategic Plan (NSP). The Anova Health Institute supported this initiative by developing the sex-positive model for addressing MSM sexual health – with an emphasis on HIV – for implementation throughout South Africa. Health4Men provides a comprehensive package that includes combination HIV prevention linked to competent MSM sexual health and HIV services. Health4Men now has services throughout the country. Two clinics have been awarded the title of Centres Of Excellence (COE) for their specialised HIV-related care and treatment – the Ivan Toms Centre for Men’s Health in Woodstock, Cape Town and the Yeoville clinic in Johannesburg. MSM, competent services are integrated into public health facilities to maximise reach and sustainability. In addition to MSM services, Health4Men focuses on the health needs of other high-risk male populations, including displaced persons and refugees, prison populations, commercial sex workers and intravenous drug users. The Anova Health Institute undertakes research and specialises in innovative projects that extend to hard-to-reach populations. The Health4Men project has significant expertise in preventative interventions specifically with diverse groupings of MSM. Download the Top to Bottom Manual

From Top to Bottom – A Sex-Positive Approach For Men Who Have Sex With Men Read More »

NIMART implementation in Soweto

Anova\’s Dr Moyahabo Mabitsi shares her insight on the implementation of NIMART training that has led to an increase in access to HIV treatment in Johannesburg since more PHC facilities are providing HIV treatment services. \”In our experiences, the biggest success in implementation was based on training followed by facility-based clinical mentorship, continuous medical education and co-ordination with the District team.\”   Read full article in HIV Matters Journal, page 20, below…  HIV Matters March 2015 small-934.pdf

NIMART implementation in Soweto Read More »